“I think it’s really important that people keep signing up to these type of trials to push research forward.”
A study looking at developing new treatments for myeloma
This study is looking at developing new treatments for myeloma in the
Myeloma is a type of cancer that develops from cells in the
They also want blood and bone marrow from healthy volunteers who do not have myeloma.
The aims of this study are to
- Find out if the new drugs in the laboratory kill myeloma cells
- Develop a new test to help treat myeloma in the future
Who can enter
You may be able to enter this trial if you
- Are having your myeloma treatment at Imperial College Healthcare NHS Trust, London
- Have one of the following types of myeloma - monoclonal gammopathy, smouldering myeloma, multiple myeloma or plasmacytoma
- Do not have myeloma (are a healthy volunteer)
- Are at least 18 years old
You cannot enter this trial if you
- Have any other illness that would make you unsuitable for the study
- Are pregnant or breastfeeding
If you have myeloma there are no extra hospital visits as part of this trial. You give blood and bone marrow samples when you see the doctor as part of your routine care.
If you are a healthy volunteer the doctors will organise your visit at a time convenient for you.
Side effects of bone marrow tests include discomfort and bruising at your biopsy site. You may need some mild painkillers to take home or the doctor may suggest you take paracetamol. Very rarely you may also have bleeding, infection and pain.
You may have a small bruise where you had your blood test.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Guido Franzoso
Imperial College Healthcare NHS Trust
Medical Research Council (MRC)
NIHR Clinical Research Network: Cancer